奥沙利铂治疗后局灶性结节性增生:多机构MRI诊断病例系列
多机构病例系列报告14例癌症患者在接受奥沙利铂治疗后新发肝脏病灶,经病理或MRI诊断为局灶性结节性增生(FNH)。从完成奥沙利铂治疗到影像识别新发FNH的平均间隔为47.6个月;14例中7例(50%)经病理(活检或切除)诊断,其余7例基于高准确性MRI特征(如肝胆期高信号或等信号)诊断;随访中75%患者出现病灶增大或新病灶。作者结论认为识别这些病灶的典型MRI表现可避免不必要的活检或手术并减轻患者焦虑。
要点
- 奥沙利铂治疗后新发肝脏病灶可经MRI典型表现(肝胆期高信号或等信号)诊断为FNH。
- 本系列中从完成奥沙利铂治疗到影像识别新发FNH的平均间隔为47.6个月。
- 随访中75%患者出现病灶增大或新发病灶,但FNH为良性,识别典型MRI表现可避免不必要活检或手术。
核心结论
- 奥沙利铂治疗后新发肝脏病灶可为FNH;识别其典型MRI表现可能避免不必要的活检或手术并减轻患者焦虑。
研究设计与样本
- 多机构病例系列,纳入14例有奥沙利铂治疗史并新发肝脏病灶的成人癌症患者(8男6女),病灶经病理分析或MRI或两者诊断为FNH;回顾影像与病理特征、化疗后间隔及时间演变。
关键影像表现/征象
- 14例中7例(50%)的指标病灶经病理分析(活检或切除)诊断为FNH。
- 其余7例基于高准确性MRI特征诊断,例如病灶在肝胆期图像上呈高信号或等信号。
- 影像随访中75%患者出现病灶增大或新发病灶。
诊断标准与关键数值
- MRI诊断FNH可依据高准确性特征,例如病灶在肝胆期图像上呈高信号或等信号。
- 本系列中7例(50%)经病理分析(活检或切除)确诊FNH。
临床应用与阅片要点
- 对有奥沙利铂治疗史且新发肝脏病灶的患者,阅片时应注意FNH的典型MRI表现(如肝胆期高信号或等信号)以与转移瘤鉴别。
- 作者认为识别这些病灶的典型MRI表现可能避免不必要的活检或手术并减轻患者焦虑。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Benign hepatic lesions may occur after chemotherapy treatment and may mimic metastases at imaging. We describe focal nodular hyperplasia (FNH) lesions diagnosed at MRI that occurred de novo after treatment with oxaliplatin.
MATERIALS AND METHODS: This is a multiinstitutional case series. We report 14 adult patients with cancer (eight men and six women) with a history of treatment with oxaliplatin and development of new hepatic lesions diagnosed as FNH at pathologic analysis or MRI or both. Imaging and pathology features of the included lesions, the interval since chemotherapy, and the temporal evolution were reviewed.
RESULTS: The mean interval between the completion of oxaliplatin treatment and the identification of new hepatic FNH at imaging was 47.6 months. In seven of 14 (50%) patients, the index lesion was diagnosed at pathologic analysis (biopsy or resection) as FNH. In the remaining seven cases, the diagnosis was based on highly accurate MRI features (e.g., hyper- or isointensity of the lesion on hepatobiliary phase images). Lesion growth or occurrence of new lesions was present in 75% of patients at imaging follow-up.
CONCLUSION: FNH lesions can occur de novo after treatment with oxaliplatin. Recognizing the typical MRI appearance of these lesions may avoid unnecessary biopsy or surgery and reduce patients' anxiety.
引用
- Furlan A, Brancatelli G, Dioguardi Burgio M, et al. Focal Nodular Hyperplasia After Treatment With Oxaliplatin: A Multiinstitutional Series of Cases Diagnosed at MRI. AJR Am J Roentgenol. 2018. PMID: 29323545. doi:10.2214/AJR.17.18867
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。